This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mbongo, N.
Right arrow Articles by Robert-Gero, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mbongo, N.
Right arrow Articles by Robert-Gero, M.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, February 1998, p. 352-357, Vol. 42, No. 2
0066-4804/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.

Mechanism of Amphotericin B Resistance in Leishmania donovani Promastigotes

Nicolas Mbongo,1 Philippe M. Loiseau,2,* Marie A. Billion,1 and Malka Robert-Gero1

Institut de Chimie des Substances Naturelles, CNRS, F-91190, Gif sur Yvette,1 and Biologie et Contrôle des Organismes Parasites, Faculté de Pharmacie, Université de Paris-Sud, F-92296, Châtenay-Malabry,2 France

Received 23 June 1997/Returned for modification 17 November 1997/Accepted 3 December 1997

Amphotericin B (AmB)-resistant Leishmania donovani promastigotes were selected by increasing drug pressure, and their biological features were compared with those of the wild-type parent strain. The 50% inhibitory concentration for resistant cells was 20 times higher than that for the wild-type. Resistance was stable after more than 40 passages in drug-free medium, and resistant promastigotes were infective to macrophages in vitro but lost their virulence in vivo. They had 2.5 times longer generation time, decreased AmB uptake, and increased AmB efflux in comparison to the wild type. Fluorescence measurement with a specific plasma membrane probe, 1-[4-(trimethylammonio)-1,6-diphenylhexa]-1,3,5-triene, showed increased membrane fluidity in drug-resistant promastigotes. Analysis of lipid composition showed that in resistant cells saturated fatty acids were prevalent, with stearic acid as the major fatty acid, and the major sterol was an ergosterol precursor, the cholesta-5, 7, 24-trien-3beta -ol and not ergosterol as in the AmB-sensitive strain.

* Corresponding author. Mailing address: Biologie et Contrôle des Organismes Parasites, Faculté de Pharmacie, Université de Paris-Sud, F-92296, Châtenay-Malabry, France. Phone: 33 1 46 83 55 54. Fax: 33 1 46 83 55 57. E-mail: philippe.loiseau{at}cep.u-psud.fr.

Antimicrobial Agents and Chemotherapy, February 1998, p. 352-357, Vol. 42, No. 2
0066-4804/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:

  • Saint-Pierre-Chazalet, M., Ben Brahim, M., Le Moyec, L., Bories, C., Rakotomanga, M., Loiseau, P. M. (2009). Membrane sterol depletion impairs miltefosine action in wild-type and miltefosine-resistant Leishmania donovani promastigotes. J Antimicrob Chemother 64: 993-1001 [Abstract] [Full Text]  
  • Vermeersch, M., da Luz, R. I., Tote, K., Timmermans, J.-P., Cos, P., Maes, L. (2009). In Vitro Susceptibilities of Leishmania donovani Promastigote and Amastigote Stages to Antileishmanial Reference Drugs: Practical Relevance of Stage-Specific Differences. Antimicrob. Agents Chemother. 53: 3855-3859 [Abstract] [Full Text]  
  • Rakotomanga, M., Blanc, S., Gaudin, K., Chaminade, P., Loiseau, P. M. (2007). Miltefosine Affects Lipid Metabolism in Leishmania donovani Promastigotes. Antimicrob. Agents Chemother. 51: 1425-1430 [Abstract] [Full Text]  
  • Croft, S. L., Sundar, S., Fairlamb, A. H. (2006). Drug Resistance in Leishmaniasis. Clin. Microbiol. Rev. 19: 111-126 [Abstract] [Full Text]  
  • Al-Mohammed, H. I., Chance, M. L., Bates, P. A. (2005). Production and Characterization of Stable Amphotericin-Resistant Amastigotes and Promastigotes of Leishmania mexicana. Antimicrob. Agents Chemother. 49: 3274-3280 [Abstract] [Full Text]  
  • Rakotomanga, M., Saint-Pierre-Chazalet, M., Loiseau, P. M. (2005). Alteration of Fatty Acid and Sterol Metabolism in Miltefosine-Resistant Leishmania donovani Promastigotes and Consequences for Drug-Membrane Interactions. Antimicrob. Agents Chemother. 49: 2677-2686 [Abstract] [Full Text]  
  • Mangoni, M. L., Saugar, J. M., Dellisanti, M., Barra, D., Simmaco, M., Rivas, L. (2005). Temporins, Small Antimicrobial Peptides with Leishmanicidal Activity. J. Biol. Chem. 280: 984-990 [Abstract] [Full Text]  
  • Pourshafie, M., Morand, S., Virion, A., Rakotomanga, M., Dupuy, C., Loiseau, P. M. (2004). Cloning of S-Adenosyl-L-Methionine:C-24-{Delta}-Sterol-Methyltransferase (ERG6) from Leishmania donovani and Characterization of mRNAs in Wild-Type and Amphotericin B-Resistant Promastigotes. Antimicrob. Agents Chemother. 48: 2409-2414 [Abstract] [Full Text]  
  • Larabi, M., Yardley, V., Loiseau, P. M., Appel, M., Legrand, P., Gulik, A., Bories, C., Croft, S. L., Barratt, G. (2003). Toxicity and Antileishmanial Activity of a New Stable Lipid Suspension of Amphotericin B. Antimicrob. Agents Chemother. 47: 3774-3779 [Abstract] [Full Text]  
  • Loiseau, P. M., Imbertie, L., Bories, C., Betbeder, D., De Miguel, I. (2002). Design and Antileishmanial Activity of Amphotericin B-Loaded Stable Ionic Amphiphile Biovector Formulations. Antimicrob. Agents Chemother. 46: 1597-1601 [Abstract] [Full Text]  
  • Espuelas, S., Legrand, P., Loiseau, P. M., Bories, C., Barratt, G., Irache, J. M. (2000). In Vitro Reversion of Amphotericin B Resistance in Leishmania donovani by Poloxamer 188. Antimicrob. Agents Chemother. 44: 2190-2192 [Abstract] [Full Text]  
  • DANNAOUI, E., BOREL, E., PERSAT, F., PIENS, M.A., PICOT, S. (2000). Amphotericin B resistance of Aspergillus terreus in a murine model of disseminated aspergillosis. J Med Microbiol 49: 601-606 [Abstract] [Full Text]  
  • Ghannoum, M. A., Rice, L. B. (1999). Antifungal Agents: Mode of Action, Mechanisms of Resistance, and Correlation of These Mechanisms with Bacterial Resistance. Clin. Microbiol. Rev. 12: 501-517 [Abstract] [Full Text]  
  • Di Giorgio, C., Faraut-Gambarelli, F., Imbert, A., Minodier, P., Gasquet, M., Dumon, H. (1999). Flow cytometric assessment of amphotericin B susceptibility in Leishmania infantumisolates from patients with visceral leishmaniasis. J Antimicrob Chemother 44: 71-76 [Abstract] [Full Text]  
  • Gangneux, J.-P., Dullin, M., Sulahian, A., Garin, Y. J.-F., Derouin, F. (1999). Experimental Evaluation of Second-Line Oral Treatments of Visceral Leishmaniasis Caused by Leishmania infantum. Antimicrob. Agents Chemother. 43: 172-174 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»